Philip Diaz, MD
Critical Care Medicine · Columbus, OHNPI 1114930476
Payments from drug & device makers
What this record shows
This record is dominated by education: $17 of the $17 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Insmed, Inc.. That places this record below the midpoint for critical care medicine clinicians in OH, where the typical reported total is $264.
Across 1 payment — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$17
Across 10 payments — averaging $11,014 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$104K
- Insmed, Inc.$6K
What the payments were for
- Education$17100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insmed, Inc. | 1 | $17 |
How this compares
$17 in reported general payments places this provider in the 5th percentile of 285 critical care medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 34 | $447,334 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 393 | $302,512 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 178 | $129,858 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 129 | $72,345 |
| Spiriva RespimatTiotropium Bromide | 80 | $70,558 |
| Fasenra PenBenralizumab | 12 | $64,700 |
| Breo ElliptaFluticasone/Vilanterol | 97 | $54,797 |
| Incruse ElliptaUmeclidinium Bromide | 89 | $49,322 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 83 | $45,124 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 59 | $43,349 |
| Spiriva HandihalerTiotropium Bromide | 24 | $25,313 |
| SymbicortBudesonide/Formoterol Fumarate | 52 | $16,023 |
| Advair HfaFluticasone Propion/Salmeterol | 21 | $15,739 |
| Varenicline Tartrate | 56 | $15,075 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 441 | $13,347 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Columbus
- Nicholas PastisColumbus$145K
- Michael EssandohColumbus$135K
- Kari GorderColumbus$20K
- Elliott CrouserColumbus$16K
- Shailesh PintoColumbus$7K
- John ChristmanColumbus$5K
- Jennifer JamesColumbus$2K
- Jared CollinsColumbus$1K
- Neal ChaissonCleveland$428K
- Robert SchilzCleveland$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.